Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial



Kudo, Masatoshi, Ueshima, Kazuomi, Yokosuka, Osamu, Ogasawara, Sadahisa, Obi, Shuntaro, Izumi, Namiki, Aikata, Hiroshi, Nagano, Hiroaki, Hatano, Etsuro, Sasaki, Yutaka
et al (show 13 more authors) (2018) Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial. LANCET GASTROENTEROLOGY & HEPATOLOGY, 3 (6). 424 - 432.

[img] Text
SILIUS manuscript 10.07.17.pdf - Accepted Version

Download (972kB)
Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 12 Jun 2018 13:55
Last Modified: 30 Nov 2019 01:13
DOI: 10.1016/S2468-1253(18)30078-5
Related URLs:
URI: http://livrepository.liverpool.ac.uk/id/eprint/3022478
Repository Staff Access